Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel
Uitgebreid zoeken

Amerikaanse aandelen Terug naar discussie overzicht

Cannabis aandelen

8.264 Posts
Pagina: «« 1 ... 58 59 60 61 62 ... 414 »» | Laatste | Omlaag ↓
  4. D-ke 25 januari 2018 11:18

    • D-ke

      Lid sinds: 20 nov 2017

      Laatste bezoek: 27 jul 2022

    • Aanbevelingen

      Ontvangen: 3

      Gegeven: 0

    •    Aantal posts: 48

    hoe en wanneer worden de aandelen van Cannimed overgezet in aandelen Aurora?
    ik veronderstel dat je bericht van je Broker krijgt gezien je keuze hebt tussen aandelen of cash en/of moet je zelf iets ondernemen?

    grt
    D
  9. Vaartat 25 januari 2018 12:31

    • Vaartat

      Lid sinds: 25 jan 2018

      Laatste bezoek: 27 jul 2022

    • Aanbevelingen

      Ontvangen: 1

      Gegeven: 0

    •    Aantal posts: 13

    Ondertussen twee maanden in enkele Cannabis aandelen en vooral nog een beginner. Maar er zijn enkele 'kleine' (klein in de zin van: goedkoop) cannabis bedrijven die nog interessant zijn om aandelen in te kopen, en zeker met het oog de nieuwe ETF's die eraan zitten te komen; zeker de Horizons Marijuana junior.

    ABcann Global Corp
    Hydropothecary

    Ook WEEDMD.inc is nog vrij goedkoop; behoort tot de Horizons Marijuana ETF sinds 15 januari.

    Hebben andere mensen nog aandelen in één van deze drie?
  12. forum rang 4 Rider 25 januari 2018 12:55

    • Rider

      Lid sinds: 26 sep 2016

      Laatste bezoek: 19 apr 2024

    • Aanbevelingen

      Ontvangen: 414

      Gegeven: 141

    •    Aantal posts: 3.699

    quote:

    geen naam & geen geld schreef op 25 januari 2018 12:46:

    vandaag bijkopen of nog wachten to ze verder zakken? :)
    Vandaag nog wat Emblem bijkopen is gisteren bijna 10% gezakt. Als Aurora nog wat zakt koop ik er ook. Verder nog Organigram in port.
  13. Empros 25 januari 2018 13:03

    • Empros

      Lid sinds: 08 nov 2016

      Laatste bezoek: 18 apr 2024

    • Aanbevelingen

      Ontvangen: 55

      Gegeven: 29

    •    Aantal posts: 929

    quote:

    Vaartat schreef op 25 januari 2018 12:31:

    Ondertussen twee maanden in enkele Cannabis aandelen en vooral nog een beginner. Maar er zijn enkele 'kleine' (klein in de zin van: goedkoop) cannabis bedrijven die nog interessant zijn om aandelen in te kopen, en zeker met het oog de nieuwe ETF's die eraan zitten te komen; zeker de Horizons Marijuana junior.

    ABcann Global Corp
    Hydropothecary

    Ook WEEDMD.inc is nog vrij goedkoop; behoort tot de Horizons Marijuana ETF sinds 15 januari.

    Hebben andere mensen nog aandelen in één van deze drie?
    Hydropothecary

    Zie blz 52 dd 23/01 19.32h

  14. forum rang 5 DurianCS 25 januari 2018 14:05

    • DurianCS

      Lid sinds: 20 jan 2010

      Laatste bezoek: 19 apr 2024

    • Aanbevelingen

      Ontvangen: 2313

      Gegeven: 8553

    •    Aantal posts: 9.638

    quote:

    Vaartat schreef op 25 januari 2018 12:31:

    Ondertussen twee maanden in enkele Cannabis aandelen en vooral nog een beginner. Maar er zijn enkele 'kleine' (klein in de zin van: goedkoop) cannabis bedrijven die nog interessant zijn om aandelen in te kopen, en zeker met het oog de nieuwe ETF's die eraan zitten te komen; zeker de Horizons Marijuana junior.

    ABcann Global Corp
    Hydropothecary

    Ook WEEDMD.inc is nog vrij goedkoop; behoort tot de Horizons Marijuana ETF sinds 15 januari.

    Hebben andere mensen nog aandelen in één van deze drie?
    ABcann en Hydropothecary, waarbij vooral de eerste het heel goed doet.
  16. cdbe 25 januari 2018 14:42

    • cdbe

      Lid sinds: 11 jan 2018

      Laatste bezoek: 18 apr 2024

    • Aanbevelingen

      Ontvangen: 286

      Gegeven: 35

    •    Aantal posts: 1.247

    Ik heb de mijn van Emblem en CBW ook op de verkeerde moment gekocht
  17. Empros 25 januari 2018 14:49

    • Empros

      Lid sinds: 08 nov 2016

      Laatste bezoek: 18 apr 2024

    • Aanbevelingen

      Ontvangen: 55

      Gegeven: 29

    •    Aantal posts: 929

    quote:

    Karel-B schreef op 25 januari 2018 14:32:

    verdomme ik koop elke keer op het verkeerde moment, net weer canopy gehaald á €23,20 en dan zie ik waar ze nu staan :(
    Enige verwantschap met Mr.Bean? :)
    Sorry Karel, dien bal kon ik niet laten liggen hé.
  19. [verwijderd] 25 januari 2018 15:00

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Komt goed Karel jonge
    Canopy Growth Finalizes Key Component of Canadian Hemp Strategy by Closing Previously Announced Green Hemp Acquisition
    Canada NewsWire

    YORKTON, SK, Jan. 25, 2018

    Grasslands Site Now Licensed for Cannabis Sale - Will Add Hemp Processing Capabilities

    YORKTON, SK, Jan. 25, 2018 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) is pleased to announce that it has closed the previously announced acquisition of assets and intellectual property from Green Hemp Industrie Ltd. ("Green") and has welcomed Green's Principal and Founder, Jason Green to the Canopy Growth family.

    Canopy Growth will combine its own expertise in large-scale cannabinoid extraction processes with Green's unique whole-plant hemp harvesting knowledge and library of stable CBD-rich hemp genetics to position the Company as a global leader in low-cost, high yield CBD production.

    By diversifying its operations to include hemp harvesting and extraction, the Company will be investing in an innovative new agricultural sector and creating jobs for Saskatchewanians. The field operations alone are ready to scale from 600 acres in 2018 to 2,500 acres in 2019. To support this growth, custom built extraction infrastructure will be installed at Canopy's Tweed Grasslands facility.

    As an innovative new sector, Canopy Growth's strategy has been welcomed by the provincial government. Saskatchewan is a natural fit for field scale hemp production. The provincial economy is positioned to benefit from Canada's largest cannabis company anchoring its hemp operations in Saskatchewan.

    "Saskatchewan provides an excellent platform for value-added innovation that enables diversification, commercialization and market development," said the Honourable Steven Bonk, Minister of Economy, Saskatchewan. "As one of Canada's leaders in commercial hemp production, Saskatchewan is well-positioned to attract investments from businesses like Canopy and benefit from the job growth this brings. We will continue to encourage responsible development of this industry in our province."

    The Tweed Grasslands facility last week passed a significant licensing milestone by receiving its sales licence under the Access to Cannabis for Medical Purposes Regulations (ACMPR). This is the eighth ACMPR licence and seventh sales licence held by Canopy Growth subsidiaries. Cannabis operations will continue at the site alongside the addition of hemp processing capabilities. Management believes that the logistical advantages of having its hemp production and processing in the same province will improve the efficiency of its CBD supply chain.

    As a licensed ACMPR facility Grasslands is in a unique position to perform cannabinoid extraction on hemp crops grown by third party farmers. Canopy is open for hemp business in Saskatchewan.

    "This strategy will fundamentally change the economics of CBD-based products on the market today," said Mark Zekulin, President, Canopy Growth. "Whether extracted oils formatted for medically-authorized customers or over the counter offerings should regulations permit, look for Canopy to continue its commitment to patients by providing a range of high-quality products at competitive prices."

    On closing, the Company issued 24,576 common shares. The Company may issue up to another 24,576 common shares if certain production related milestones are achieved.

    Here's to Future (Hemp) Growth.

    About Canopy Growth Corporation
    Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

    Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Organa Brands, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands. Canopy Growth operates seven cannabis production sites with over 665,000 square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.

    Notice Regarding Forward Looking Statements
    This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, its subsidiaries, or its affiliates to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

    Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.



    SOURCE Canopy Growth Corporation

    View original content: www.newswire.ca/en/releases/archive/J...
  20. [verwijderd] 25 januari 2018 15:00

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    Empros schreef op 25 januari 2018 14:49:

    [...]

    Enige verwantschap met Mr.Bean? :)
    Sorry Karel, dien bal kon ik niet laten liggen hé.
    jij mag dat! al snap ik de bal niet..
8.264 Posts
Pagina: «« 1 ... 58 59 60 61 62 ... 414 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.282
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.579 46.083
ABO-Group 1 18
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.870
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.146
Aedifica 2 828
Aegon 3.257 320.010
AFC Ajax 537 7.010
Affimed NV 2 5.735
ageas 5.843 109.775
Agfa-Gevaert 13 1.854
Ahold 3.536 73.977
Air France - KLM 1.024 34.302
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.682
Alfen 12 16.000
Allfunds Group 3 1.122
Almunda Professionals (vh Novisource) 651 4.246
Alpha Pro Tech 1 17
Alphabet Inc. 1 324
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.484 114.756
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.819 240.155
AMG 965 125.587
AMS 3 73
Amsterdam Commodities 303 6.512
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 381
Antonov 22.632 153.605
Aperam 91 14.103
Apollo Alternative Assets 1 17
Apple 5 313
Arcadis 251 8.613
Arcelor Mittal 2.023 318.575
Archos 1 1
Arcona Property Fund 1 266
arGEN-X 15 9.092
Aroundtown SA 1 175
Arrowhead Research 5 9.248
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.533
ASML 1.762 76.468
ASR Nederland 18 4.117
ATAI Life Sciences 1 7
Atenor Group 1 322
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.626
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.657

Macro & Bedrijfsagenda

  1. 19 april

    1. Japan inflatie maart 2,7% YoY volitaliteit verwacht
    2. WDP Q1-cijfers
    3. EU producentenprijzen maart
    4. VK detailhandelsverkopen maart
    5. Fra ondernemersvertrouwen april
    6. KPN €0,098 ex-dividend
    7. CM.com jaarvergadering
    8. NSI jaarvergadering
    9. American Express Q1-cijfers

  2. 22 april

    1. NL investeringen februari
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht
Naar de hele agenda